| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/29/2006 | WO2006066885A1 Substituted n-heterocyclic compounds and their use as dopamine d3 receptor ligands |
| 06/29/2006 | WO2006066790A1 Tetralin and indane derivatives and uses thereof |
| 06/29/2006 | WO2006066512A1 Pyrimidinone compounds, their preparation and use thereof |
| 06/29/2006 | WO2006017836A3 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (bace) |
| 06/29/2006 | US20060142612 Arylsulfonamide derivatives |
| 06/29/2006 | US20060142576 Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods |
| 06/29/2006 | US20060142575 Hetereoaryl nitrile derivatives |
| 06/29/2006 | US20060142571 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines |
| 06/29/2006 | US20060142315 Substituted biaryl piperazinyl-pyridine analogues |
| 06/29/2006 | US20060142277 Substituted aralkyl derivatives |
| 06/29/2006 | DE4409431B4 Cyanophenylpyri(mi)din-Derivate und flüssigkristallines Medium Cyanophenylpyri (mi) dine derivatives and liquid crystalline medium |
| 06/29/2006 | DE10038110B4 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
| 06/29/2006 | CA2592170A1 Glycine derivative and use thereof |
| 06/29/2006 | CA2591937A1 Tetralin and indane derivatives and uses thereof |
| 06/29/2006 | CA2589775A1 Process for preparing rosuvastatin |
| 06/29/2006 | CA2586973A1 Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs |
| 06/28/2006 | EP1674464A1 Novel thrombin inhibitors |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673354A1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 06/28/2006 | EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 06/28/2006 | EP1673352A1 Sulfoximine-substituted pyrimidines for use as cdk and/or vegf inhibitors, the production thereof and their use as drugs |
| 06/28/2006 | EP1673351A1 A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step |
| 06/28/2006 | EP1673350A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/28/2006 | EP1673085A2 C-met modulators and methods of use |
| 06/28/2006 | CN1795180A Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
| 06/28/2006 | CN1794996A Macrocyclic quinazoline derivatives as antiproliferative agents |
| 06/28/2006 | CN1794987A Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 06/28/2006 | CN1793120A Thiourea kind compund with inhibiting virus capsid protain activity and its preparation process and application thereof |
| 06/28/2006 | CN1261525C Liquid crystal mixture |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067664 Corticotropin releasing factor antagonists |
| 06/27/2006 | US7067663 Triazolo pyrimidine compounds |
| 06/27/2006 | US7067662 CXCR3 antagonists |
| 06/27/2006 | US7067655 Adenosine A2a receptor antagonists |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
| 06/27/2006 | US7067522 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067514 Pyrimidine compounds |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/22/2006 | WO2006065590A2 Pyridine and pyrimidine antiviral compositions |
| 06/22/2006 | WO2006065277A2 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | WO2006042289A3 Substituted biaryl quinolin-4-ylamine analogues |
| 06/22/2006 | WO2006028904A9 Quinazolines useful as modulators of ion channels |
| 06/22/2006 | US20060135554 Novel compounds |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135517 Imidazolopyridines and methods of making and using the same |
| 06/22/2006 | US20060135367 2,5 -Difluoro-N-isobutyl-N-(8-propyl-[1,2,4]triazolo,[1,5-c]pyrimidin-7-ylmethyl)-benzamide; gamma aminobutyric acid receptor (GABAR) agonist/antagonist; anxiolitic, antidepressant; sleep disorder, attention deficit disorder, schizophrenia or Alzheimer's dementia |
| 06/22/2006 | US20060134767 Mitotic kinesin binding site |
| 06/22/2006 | DE102004061593A1 Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung Substituted N-heterocyclic compounds and their therapeutic use |
| 06/22/2006 | DE102004059488A1 Preparation of alloxane-5-hydrazone compound comprises condensation of alloxane compound with hydrazine in the present of sulfite salt |
| 06/22/2006 | CA2591588A1 Processes for producing 4-aminoquinazolines |
| 06/22/2006 | CA2591033A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | CA2590851A1 Crystal structure of enzyme and uses thereof |
| 06/22/2006 | CA2590250A1 Pyrimidine inhibitors of erk protein kinase and uses therof |
| 06/21/2006 | EP1671973A2 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP1670787A2 Cytokine inhibitors |
| 06/21/2006 | EP1670781A1 Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof |
| 06/21/2006 | EP1670778A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity |
| 06/21/2006 | EP1670771A1 Compounds and compositions as protein kinase inhibitors |
| 06/21/2006 | EP1670763A1 Cyclopentene compounds |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | EP1670458A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791583A 2-substituted pyrimidines. |
| 06/21/2006 | CN1791580A Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1791410A Methods for treating or preventing an inflammatory or metabolic condition by inhibiting JNK |
| 06/21/2006 | CN1791409A (3-{3-' (2,4-bis- trifluormethyl -benzyl)-(5 -ethyl-pyrimidin -2-yl)- amino! -propoxy} -phenyl) -acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 06/20/2006 | US7064205 Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
| 06/20/2006 | CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2259183C Fluorous reaction and separation systems |
| 06/20/2006 | CA2177392C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 06/20/2006 | CA2135480C Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006061417A2 Macrocyclic quinazole derivatives and their use as mtki |
| 06/15/2006 | WO2006061415A1 2,4 (4,6) pyrimidine derivatives |
| 06/15/2006 | WO2006044823A3 Heteroaryl-substituted alkyne compounds and method of use |
| 06/15/2006 | WO2005085188A3 Compounds and methods for anti-tumor therapy |
| 06/15/2006 | US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 06/15/2006 | US20060128692 Non nucleoside reverse transcriptase inhibitors |
| 06/15/2006 | US20060127487 Antiviral compositions |
| 06/15/2006 | CA2590115A1 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
| 06/15/2006 | CA2588764A1 Macrocyclic quinazole derivatives and their use as mtki |
| 06/15/2006 | CA2588761A1 2,4(4,6)pyrimidine derivatives |
| 06/14/2006 | EP1669357A1 SUBSTANCE WHICH EXHIBITS ANTIVIRAL AND ANTIBACTERIAL ACTIVITY AND IS BASED ON DERIVATIVES OF 2,8-DITHIOXO-1H-PYRANO 2,3D&cedi l;6,5-D DIPYRIMIDYNE AND 10-AZA-ANALOGUE THEREOF |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1667997A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof |
| 06/14/2006 | EP1667985A1 Substituted pyrimidines as ligands of adenosine receptors |
| 06/14/2006 | EP1667966A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 06/14/2006 | EP1667962A1 Aminoalkylamide substituted cyclohexyl derivatives |